Wen-Chi Yang

577 total citations
22 papers, 392 citations indexed

About

Wen-Chi Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wen-Chi Yang has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wen-Chi Yang's work include Advanced Radiotherapy Techniques (4 papers), Brain Metastases and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). Wen-Chi Yang is often cited by papers focused on Advanced Radiotherapy Techniques (4 papers), Brain Metastases and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). Wen-Chi Yang collaborates with scholars based in Taiwan. Wen-Chi Yang's co-authors include Feng‐Ming Hsu, Pan‐Chyr Yang, Sung‐Hsin Kuo, Jason Chia‐Hsien Cheng, Ya‐Fang Chen, Jui-Feng Hsu, Sheng-Fung Lin, Cheng‐Ming Hsu, Ming‐Yu Yang and Hui‐Hua Hsiao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Journal of Cancer.

In The Last Decade

Wen-Chi Yang

19 papers receiving 383 citations

Peers

Wen-Chi Yang
Dejun Zhou China
Eiko Nakata Japan
Alexander Kirichenko United States
Qiang Zeng China
Mingyan He China
Mengjie Tang China
Minhua Lu China
Maria Comănescu Romania
Dejun Zhou China
Wen-Chi Yang
Citations per year, relative to Wen-Chi Yang Wen-Chi Yang (= 1×) peers Dejun Zhou

Countries citing papers authored by Wen-Chi Yang

Since Specialization
Citations

This map shows the geographic impact of Wen-Chi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Chi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Chi Yang more than expected).

Fields of papers citing papers by Wen-Chi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Chi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Chi Yang. The network helps show where Wen-Chi Yang may publish in the future.

Co-authorship network of co-authors of Wen-Chi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Chi Yang. A scholar is included among the top collaborators of Wen-Chi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Chi Yang. Wen-Chi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Wen-Chi, Yu‐Hsuan Chen, Chia‐Chun Wang, et al.. (2025). Evaluation of cardiotoxicity following breast cancer irradiation in an Asian cohort in real-world settings. The Breast. 84. 104581–104581.
2.
Yang, Wen-Chi, et al.. (2025). Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments. Journal of the Formosan Medical Association.
3.
Chen, Yilun, Wen-Chi Yang, Wei‐Hsin Lin, et al.. (2025). 1989 Phase II randomized trial of elective versus involved target irradiation in stereotactic spine radiosurgery (NCT04033536). Radiotherapy and Oncology. 206. S1503–S1505.
4.
Yang, Wen-Chi, Ming‐Feng Wei, Ying‐Chun Shen, Chiun‐Sheng Huang, & Sung‐Hsin Kuo. (2025). CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer. Journal of Biomedical Science. 32(1). 79–79. 1 indexed citations
5.
Yang, Wen-Chi, Ming‐Feng Wei, Yi‐Hsuan Lee, Chiun‐Sheng Huang, & Sung‐Hsin Kuo. (2024). Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway. Translational Oncology. 49. 102092–102092. 4 indexed citations
6.
Liao, Bin-Chi, et al.. (2024). Locally advanced thymoma treated with lattice radiotherapy: a case report. 8. 8–8. 1 indexed citations
7.
Geng, Jingshu, Zhiqiang Yu, Wenxu Sun, et al.. (2024). 14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy. European Journal of Cancer. 211. 114543–114543. 2 indexed citations
8.
Kuo, Sung‐Hsin, Ming‐Feng Wei, Yi‐Hsuan Lee, et al.. (2023). MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology. 46(5). 1213–1234. 10 indexed citations
9.
Wu, Chun‐Yu, Yen‐Heng Lin, Yucheng Huang, et al.. (2023). Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes. Neurospine. 20(4). 1431–1442. 4 indexed citations
10.
Chen, Ko‐Ting, Chiung-Yin Huang, Ping‐Ching Pai, et al.. (2023). Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study. Journal of Neuro-Oncology. 165(3). 535–545. 20 indexed citations
11.
Cheng, Jason Chia‐Hsien, et al.. (2021). A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Journal of the Formosan Medical Association. 120(12). 2176–2185. 1 indexed citations
12.
Xiao, Furen, Jason Chia‐Hsien Cheng, Wen-Chi Yang, et al.. (2021). Randomized multi-reader evaluation of automated detection and segmentation of brain tumors in stereotactic radiosurgery with deep neural networks. Neuro-Oncology. 23(9). 1560–1568. 38 indexed citations
13.
Yang, Wen-Chi, Ya‐Fang Chen, Chi-Cheng Yang, et al.. (2020). Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial. Neuro-Oncology. 23(3). 478–486. 43 indexed citations
14.
Yang, Wen-Chi, Feng‐Ming Hsu, Yu‐Hsuan Chen, et al.. (2020). Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer. Clinical and Translational Radiation Oncology. 22. 76–82. 11 indexed citations
15.
Yang, Wen-Chi, Feng‐Ming Hsu, & Pan‐Chyr Yang. (2020). Precision radiotherapy for non-small cell lung cancer. Journal of Biomedical Science. 27(1). 82–82. 51 indexed citations
16.
Yang, Wen-Chi, Furen Xiao, Jin‐Yuan Shih, et al.. (2017). Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery. Radiotherapy and Oncology. 126(2). 368–374. 20 indexed citations
17.
Yang, Wen-Chi, et al.. (2016). Complete response of myeloid sarcoma with cardiac involvement to radiotherapy. Journal of Thoracic Disease. 8(6). 1323–1328. 3 indexed citations
18.
Yang, Ming‐Yu, Pai‐Mei Lin, Yi‐Chang Liu, et al.. (2012). Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells. PLoS ONE. 7(5). e37205–e37205. 63 indexed citations
19.
Huang, Chi‐Chou, Tzu‐Chin Wu, Hsien‐Chun Tseng, et al.. (2009). Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytotherapy Research. 23(6). 785–790. 94 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dejun Zhou Breakdown of academic impact, for papers by Eiko Nakata Breakdown of academic impact, for papers by Alexander Kirichenko Breakdown of academic impact, for papers by Qiang Zeng Breakdown of academic impact, for papers by Mingyan He Breakdown of academic impact, for papers by Mengjie Tang Breakdown of academic impact, for papers by Minhua Lu Breakdown of academic impact, for papers by Maria Comănescu
Rankless by CCL
2026